Selective serotonin reuptake inhibitors are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions. From Wikipedia
Medical groups warn the skewed risk assessment could prompt stricter regulations restricting pregnant patients’ access to essential depression treatment.
